After Using ChatGPT to Treat His Dog's Cancer, He Launches an AI MedTech Startup
The Verge AI · rss · 2026-08-12
The highly publicized story of an Australian entrepreneur using ChatGPT, Grok, and other AI tools to craft a personalized mRNA cancer vaccine for his dog has evolved into a full-fledged startup.
Entrepreneur Paul Conyngham has launched Gamgee, aiming to offer personalized mRNA cancer vaccines for dogs. The company's ambitions extend well beyond pets, promising to harness AI and genetics to develop personalized treatments for a range of diseases and species, including humans.
More from Companies & People
- Valued at $7B, Healthcare AI Firm Commure Relies on Referral Incentives Amid Customer Losses — zakkohane · 2026-08-12
- Tencent's Q2 2026: 51.4B Yuan Compute Prepayment, 10.5B Loss from AI Products — 智东西 · 2026-08-12
- AI Coding Startup Cognition in Talks to Raise Over $1B at $40B+ Valuation — nmasc_ · 2026-08-12
- Jensen Huang Tops Glassdoor's 2026 Best CEOs List with 99% Employee Approval — nvidia · 2026-08-12
- Breaking the Post-Deployment Stagnation: 20+ Startups Bet on Continual Learning — bigdata · 2026-08-12
- Codex Drives 64% of Enterprise OpenAI Tokens as Agents Take Over — soumitrashukla9 · 2026-08-12